Vascular Endothelial Growth Factor as Potential Biomarker for COVID-19 Severity.

Journal of intensive care medicine(2023)

Cited 0|Views7
No score
Abstract
Even though there are several limitations to this retrospective study it revealed that in COVID-19 patients VEGF can contribute to the prediction of necessity of ICU, mortality and the prediction of ARDS, kidney injury or shock. Its use in risk stratification and potential pathogenetic involvement should be further investigated.
More
Translated text
Key words
COVID-19, VEGF, biomarker, endothelial damage, ARDS, mortality, risk stratification
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined